Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
Not found in filings
$5.0bn
$4.5bnEST
n/a
Share repurchase plan publicly announced and approved by the Board of Directors in November 2022. At July 31, 2026, $1.58 billion remained available for repurchase under this program. Plans do not have a fixed expiration date and may include open market transactions, privately negotiated transactions, accelerated share repurchase programs, tender offers, or by other means.10-Q filed 28-Aug-26
Not found in filings
$5.0bn
$4.5bnEST
n/a
Share repurchase plan publicly announced and approved by the Board of Directors in November 2024. At July 31, 2026, $5 billion remained available for repurchase under this program. Plans do not have a fixed expiration date and may include open market transactions, privately negotiated transactions, accelerated share repurchase programs, tender offers, or by other means.10-Q filed 28-Aug-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)